2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Biological activity
Description
CAS NO.：146535-11-7 Product Name：6,7-dimethoxy-2-phenylquinoxaline Synonyms：Tyrphostin AG 1296;AG 1296;AG1296 EINEC: Molecular Formula：C16H14N2O2 Molecular Weight：266.3
Target:
PDGFRα
PDGFRβ
In Vivo
Tyrphostin AG1296 (0.625-20 μM; 72 h) suppresses viability of PLX4032-resistant melanoma cells[4]. Tyrphostin AG1296 (2.5-20 μM; 48 h) induces apoptosis of A375R cells[4]. Tyrphostin AG1296 (5 and 20 μM; 2 h) inhibits PDGFR phosphorylation in A375R cells[4]. Tyrphostin AG1296 (0.0625-1 μM; 8 h) inhibits migration of A375R cells[4]. Cell Viability Assay[4] Cell Line: PLX4032-resistant cell lines (A375R and SK-MEL-5R) Concentration: 0.625, 1.25, 5, 20 μM Incubation Time: 72 h Result: Reduced the viability of both PLX4032-sensitive and PLX4032-resistant cell lines. Apoptosis Analysis[4] Cell Line: A375R cells Concentration: 2.5, 5, 10, 20 μM Incubation Time: 48 h Result: Induced dramatic apoptosis in A375R cells. Western Blot Analysis[4] Cell Line: A375R cells Concentration: 5, 20 μM Incubation Time: 2 h Result: Inhibited phosphorylation of both PDGFR-α and PDGFR-β.
In Vitro
Tyrphostin AG1296 (0.625-20 μM; 72 h) suppresses viability of PLX4032-resistant melanoma cells[4]. Tyrphostin AG1296 (2.5-20 μM; 48 h) induces apoptosis of A375R cells[4]. Tyrphostin AG1296 (5 and 20 μM; 2 h) inhibits PDGFR phosphorylation in A375R cells[4]. Tyrphostin AG1296 (0.0625-1 μM; 8 h) inhibits migration of A375R cells[4]. Cell Viability Assay[4] Cell Line: PLX4032-resistant cell lines (A375R and SK-MEL-5R) Concentration: 0.625, 1.25, 5, 20 μM Incubation Time: 72 h Result: Reduced the viability of both PLX4032-sensitive and PLX4032-resistant cell lines. Apoptosis Analysis[4] Cell Line: A375R cells Concentration: 2.5, 5, 10, 20 μM Incubation Time: 48 h Result: Induced dramatic apoptosis in A375R cells. Western Blot Analysis[4] Cell Line: A375R cells Concentration: 5, 20 μM Incubation Time: 2 h Result: Inhibited phosphorylation of both PDGFR-α and PDGFR-β.
Kinase Assay
Cell Assay
Animal Administration
References
[1]. Gazit A, etm, al. Tyrphostins. 5. Potent inhibitors of platelet-derived growth factor receptor tyrosine kinase: structure-activity relationships in quinoxalines, quinolines, and indole tyrphostins. Comparative Study J Med Chem. 1996 May 24; 39(11): 2170-7.
[2]. Kovalenko M, et, al. Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation. Cancer Res. 1994 Dec 1; 54(23): 6106-14.
[3]. Tse KF, et, al. Inhibition of the transforming activity of FLT3 internal tandem duplication mutants from AML patients by a tyrosine kinase inhibitor. Leukemia. 2002 Oct; 16(10): 2027-36.
[4]. Li Y, et, al. Tyrphostin AG1296, a platelet-derived growth factor receptor inhibitor, induces apoptosis, and reduces viability and migration of PLX4032-resistant melanoma cells. Onco Targets Ther. 2015 May 14; 8: 1043-51.
[5]. Dong M, et, al. AG1296 enhances plaque stability via inhibiting inflammatory responses and decreasing MMP-2 and MMP-9 expression in ApoE-/- mice. Biochem Biophys Res Commun. 2017 Aug 5;489(4):426-431.
Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.
